Literature DB >> 20944986

Low and high-dose intradermal infection with Leishmania major and Leishmania amazonensis in C57BL/6 mice.

Denise Fonseca Côrtes1, Matheus Batista Heitor Carneiro, Liliane Martins Santos, Talita Correia de Oliveira Souza, Tatiane Uceli Maioli, Ana Luiza C Duz, Maria Letícia Ramos-Jorge, Luis Carlos Crocco Afonso, Claudia Carneiro, Leda Quercia Vieira.   

Abstract

A model of skin infection with Leishmania amazonensis with low doses of parasites is compared to infection with high doses of L. amazonensis and low and high doses of Leishmania major. C57BL/6 mice were infected with 10³ or 10(6) parasites in the ear and the outcome of infection was assessed. The appearance of lesions in mice infected with 10³ parasites was delayed compared to mice infected with 10(6) Leishmania and parasites were detectable at the infection site before lesions became apparent. Mice infected with L. amazonensis displayed persistent lesions, whereas infection with L. major spontaneously healed in all groups, although lymphocytes persisted at the site of infection after healing. Macrophages persisted only in L. amazonensis-infected mice. High-dose L. amazonensis-infected mice produced lower levels of IFN-γ and TNF than mice infected with L. major. No correlation between the persistence of parasites and IL-10 levels and the production of nitric oxide or urea by macrophages was found. We conclude that infection with low doses of L. amazonensis in the dermis changes the course of infection by delaying the appearance of lesions. However, low-dose infection does not change the outcomes of susceptibility and cytokine production described for subcutaneous infection with high numbers of parasites.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944986     DOI: 10.1590/s0074-02762010000600002

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  12 in total

Review 1.  Dependence of Leishmania parasite on host derived ATP: an overview of extracellular nucleotide metabolism in parasite.

Authors:  Kashika Arora; Ambak Kumar Rai
Journal:  J Parasit Dis       Date:  2018-12-01

2.  IFN-γ-Dependent Recruitment of CD4(+) T Cells and Macrophages Contributes to Pathogenesis During Leishmania amazonensis Infection.

Authors:  Matheus Batista Heitor Carneiro; Mateus Eustáquio de Moura Lopes; Leonardo Gomes Vaz; Louisa Maria Andrade Sousa; Liliane Martins dos Santos; Carolina Carvalho de Souza; Ana Carolina de Angelis Campos; Dawidson Assis Gomes; Ricardo Gonçalves; Wagner Luiz Tafuri; Leda Quercia Vieira
Journal:  J Interferon Cytokine Res       Date:  2015-09-24       Impact factor: 2.607

3.  RNA Extraction from Ears and Draining Lymph Nodes of Mice Infected with Leishmania amazonensis.

Authors:  Emilie Giraud; Evie Melanitou
Journal:  Bio Protoc       Date:  2020-06-05

4.  Leishmania amazonensis-Induced cAMP Triggered by Adenosine A2B Receptor Is Important to Inhibit Dendritic Cell Activation and Evade Immune Response in Infected Mice.

Authors:  Amanda Braga Figueiredo; Míriam Conceição Souza-Testasicca; Tiago Wilson Patriarca Mineo; Luís Carlos Crocco Afonso
Journal:  Front Immunol       Date:  2017-07-25       Impact factor: 7.561

5.  Photodynamic Vaccination of BALB/c Mice for Prophylaxis of Cutaneous Leishmaniasis Caused by Leishmania amazonensis.

Authors:  Sayonara M Viana; Fabiana S Celes; Laura Ramirez; Bala Kolli; Dennis K P Ng; Kwang P Chang; Camila I de Oliveira
Journal:  Front Microbiol       Date:  2018-02-06       Impact factor: 5.640

6.  Moroccan strains of Leishmania major and Leishmania tropica differentially impact on nitric oxide production by macrophages.

Authors:  Hasnaa Maksouri; Pham My-Chan Dang; Vasco Rodrigues; Jérôme Estaquier; Myriam Riyad; Khadija Akarid
Journal:  Parasit Vectors       Date:  2017-10-23       Impact factor: 3.876

7.  Dysregulation of Glycerophosphocholines in the Cutaneous Lesion Caused by Leishmania major in Experimental Murine Models.

Authors:  Adwaita R Parab; Diane Thomas; Sharon Lostracco-Johnson; Jair L Siqueira-Neto; James H McKerrow; Pieter C Dorrestein; Laura-Isobel McCall
Journal:  Pathogens       Date:  2021-05-13

8.  MPLA and AddaVax® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis.

Authors:  Diogo Oliveira-Maciel; Júlio Souza Dos-Santos; Gabriel Oliveira-Silva; Mirian França de Mello; Alessandra Marcia da Fonseca-Martins; Monique Pacheco Duarte Carneiro; Tadeu Diniz Ramos; Luan Firmino-Cruz; Daniel Claudio Oliveira Gomes; Bartira Rossi-Bergmann; Herbert Leonel de Matos Guedes
Journal:  Microorganisms       Date:  2021-06-11

9.  Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice.

Authors:  Juliana Elena Silveira Pratti; Tadeu Diniz Ramos; Joyce Carvalho Pereira; Alessandra Marcia da Fonseca-Martins; Diogo Maciel-Oliveira; Gabriel Oliveira-Silva; Mirian França de Mello; Suzana Passos Chaves; Daniel Claudio Oliveira Gomes; Bruno Lourenço Diaz; Bartira Rossi-Bergmann; Herbert Leonel de Matos Guedes
Journal:  Parasit Vectors       Date:  2016-10-06       Impact factor: 3.876

10.  Deletion of Interleukin-4 Receptor Alpha-Responsive Keratinocytes in BALB/c Mice Does Not Alter Susceptibility to Cutaneous Leishmaniasis.

Authors:  Melissa Govender; Ramona Hurdayal; Berenice Martinez-Salazar; Kaya Gqada; Shandre Pillay; Lorna Gcanga; Katiuska Passelli; Natalie E Nieuwenhuizen; Fabienne Tacchini-Cottier; Reto Guler; Frank Brombacher
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.